PSA vs REX · rev $4.82B vs P/E 15, rev $642.5M
PSA (PSA) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
PSA currently screens at market cap $0. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the PSA and REX stock pages for the full models.
Not investment advice.